Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-21 Sale(A) | 2024-07-03 9:00 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 40,000 | $35.09 | $1,403,668 | 279,977 (Direct) | View |
| 2024-06-21 Sale | 2024-06-24 8:41 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 39,950 | $35.09 | $1,401,902 | 280,027 (Direct) | View |
| 2024-06-12 Sale | 2024-06-13 9:45 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 40,000 | $33.36 | $1,334,201 | 249,278 (Direct) | View |
| 2024-06-11 Sale | 2024-06-11 7:42 pm | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 2,136 | $31.34 | $66,942 | 147,511 (Direct) | View |
| 2024-06-11 Sale | 2024-06-11 7:41 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 2,636 | $31.27 | $82,428 | 145,543 (Direct) | View |
| 2024-06-10 Sale | 2024-06-11 7:34 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 85,270 | $30.3 | $2,583,782 | 289,278 (Direct) | View |
| 2024-06-11 Sale | 2024-06-11 7:34 pm | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 1,823 | $31.34 | $57,133 | 134,811 (Direct) | View |
| 2024-06-10 Sale | 2024-06-11 7:28 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 2,921 | $30.74 | $89,779 | 113,774 (Direct) | View |
| 2024-05-20 Sale | 2024-05-22 9:01 pm | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 30,426 | $32.96 | $1,002,751 | 149,647 (Direct) | View |
| 2024-05-16 Sale | 2024-05-17 9:07 pm | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 2,705 | $28.27 | $76,469 | 149,647 (Direct) | View |
| 2024-05-16 Sale | 2024-05-17 9:06 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 2,381 | $28.27 | $67,310 | 148,179 (Direct) | View |
| 2024-05-16 Sale | 2024-05-17 9:05 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 2,738 | $28.27 | $77,402 | 154,062 (Direct) | View |
| 2024-05-16 Sale | 2024-05-17 9:04 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 2,588 | $28.27 | $73,162 | 116,695 (Direct) | View |
| 2024-05-16 Sale | 2024-05-17 9:03 pm | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 2,774 | $28.27 | $78,420 | 136,634 (Direct) | View |
| 2024-03-08 Sale | 2024-03-13 06:04 am | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 29,491 | $26.59 | $784,248 | 156,800 (Direct) | View |
| 2024-03-08 Sale | 2024-03-13 06:04 am | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 109,601 | $26.11 | $2,861,373 | 169,542 (Direct) | View |
| 2024-03-11 Sale | 2024-03-12 9:58 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 2,615 | $25.65 | $67,082 | 150,560 (Direct) | View |
| 2024-03-08 Sale | 2024-03-12 9:57 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 88,924 | $26.19 | $2,329,007 | 129,138 (Direct) | View |
| 2024-03-08 Sale | 2024-03-12 9:56 pm | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 429,730 | $25.89 | $11,125,776 | 754,536 (Direct) | View |
| 2024-03-11 Sale | 2024-03-12 9:42 pm | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 2,081 | $25.7 | $53,482 | 152,352 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 9:57 pm | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 9,086 | $25.85 | $234,873 | 554,385 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 9:56 pm | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 2,373 | $25.85 | $61,342 | 154,433 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 9:56 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 1,591 | $25.85 | $41,127 | 186,291 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 9:52 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 9,921 | $25.86 | $256,585 | 153,175 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 9:50 pm | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 2,434 | $25.85 | $62,919 | 141,184 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 9:45 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 2,273 | $25.85 | $58,757 | 121,955 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 5:08 pm | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 46,534 | $30.05 | $1,398,347 | 6,545,479 (Indirect) | View |
| 2024-03-01 Sale | 2024-03-05 5:07 pm | Dyne Therapeutics Inc. | DYN | Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner | 46,534 | $30.05 | $1,398,347 | 2,306,079 (Indirect Direct) | View |
| 2024-02-29 Sale | 2024-03-01 9:38 pm | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 100,000 | $28.96 | $2,895,519 | 1,052,995 (Direct) | View |
| 2024-02-29 Sale | 2024-03-01 9:37 pm | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 28,528 | $28.46 | $811,865 | 167,878 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-21 Exercise(A) | 2024-07-03 9:00 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 40,000 | $0 | 279,977 (Direct) | View |
| 2024-06-21 Exercise(A) | 2024-07-03 9:00 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 40,000 | $5.54 | 279,977 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-24 8:41 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 39,950 | $0 | 280,027 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-24 8:41 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 39,950 | $5.54 | 280,027 (Direct) | View |
| 2024-06-12 Exercise | 2024-06-13 9:45 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 40,000 | $0 | 249,278 (Direct) | View |
| 2024-06-12 Exercise | 2024-06-13 9:45 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 40,000 | $5.54 | 249,278 (Direct) | View |
| 2024-06-10 Exercise | 2024-06-11 7:34 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 80,000 | $0 | 289,278 (Direct) | View |
| 2024-06-10 Exercise | 2024-06-11 7:34 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 80,000 | $5.54 | 289,278 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-24 5:10 pm | N/A 2034-05-21 | Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director | 25,133 | $0 | 25,133 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-24 5:10 pm | N/A 2034-05-21 | Dyne Therapeutics Inc. | DYN | Incerti Carlo Director | 25,133 | $0 | 25,133 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-24 5:10 pm | N/A 2034-05-21 | Dyne Therapeutics Inc. | DYN | Kersten Dirk Director | 25,133 | $0 | 25,133 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-24 5:10 pm | N/A 2034-05-21 | Dyne Therapeutics Inc. | DYN | HURWITZ EDWARD Director | 25,133 | $0 | 25,133 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-24 5:10 pm | N/A 2034-05-21 | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 25,133 | $0 | 25,133 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-24 5:10 pm | N/A 2034-05-21 | Dyne Therapeutics Inc. | DYN | Lubner David Charles Director | 25,133 | $0 | 25,133 (Direct) | View |
| 2024-05-20 Exercise | 2024-05-22 9:01 pm | N/A 2030-01-05 | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 30,426 | $0 | 149,647 (Direct) | View |
| 2024-05-20 Exercise | 2024-05-22 9:01 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 30,426 | $1.03 | 149,647 (Direct) | View |
Ownership(A) | 2024-04-04 9:07 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 0 | $0 | 5,000 (Direct) | View |
| 2023-07-11 Option Award | 2024-04-04 9:06 pm | N/A 2033-07-10 | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 4:24 pm | N/A 2034-03-24 | Dyne Therapeutics Inc. | DYN | Cox John See Remarks | 679,853 | $0 | 679,853 (Direct) | View |
Ownership | 2024-03-27 4:13 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Cox John See Remarks | 0 | $0 | 10,000 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-13 06:04 am | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 107,825 | $0 | 169,542 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-13 06:04 am | N/A N/A | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 107,825 | $5.54 | 169,542 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-12 9:57 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 86,252 | $0 | 129,138 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-12 9:57 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 86,252 | $5.54 | 129,138 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-12 9:56 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 413,343 | $0 | 754,536 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-12 9:56 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 413,343 | $5.54 | 754,536 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-01 9:38 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 100,000 | $0 | 1,052,995 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-01 9:38 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 100,000 | $5.54 | 1,052,995 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-01 9:37 pm | N/A 2029-02-25 | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 28,528 | $0 | 167,878 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-01 9:37 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 28,528 | $0.73 | 167,878 (Direct) | View |